Ruixi Hu
1111 Xianxia Road
Shanghai, 200331, China
Shanghai, 200331, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
miR-16-5p Suppresses Progression and Invasion of Osteosarcoma via Targeting at Smad3.
Journal: Frontiers in pharmacology
Published: March 01, 2020
Role of the HIF‑1α/SDF‑1/CXCR4 signaling axis in accelerated fracture healing after craniocerebral injury.
Journal: Molecular medicine reports
Published: December 16, 2019
Deacylcynaropicrin Inhibits RANKL-Induced Osteoclastogenesis by Inhibiting NF-κB and MAPK and Promoting M2 Polarization of Macrophages.
Journal: Frontiers in pharmacology
Published: March 19, 2019
Beneficial effect of pristimerin against the development of osteoporosis in ovariectomy-induced osteoporosis rats by the RANKL/TRAF6/NF-κB pathway.
Journal: Archives of medical science : AMS
Published: March 08, 2019
Hypoxia changes chemotaxis behaviour of mesenchymal stem cells via HIF-1α signalling.
Journal: Journal of cellular and molecular medicine
Published: September 15, 2018
LncRNA B4GALT1-AS1 recruits HuR to promote osteosarcoma cells stemness and migration via enhancing YAP transcriptional activity.
Journal: Cell proliferation
Published: May 16, 2018
RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs.
Journal: Cell proliferation
Published: May 11, 2018
Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 07, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026